Selected research
Industry Research
Latex Allergy Industry Research Report 2026
Market perspective
The global Latex Allergy market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Latex Allergy market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Latex Allergy market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Latex Allergy market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Latex Allergy include Sanofi, Johnson & Johnson, Novartis, Merck, GlaxoSmithKline, Rocky Mountain Diagnostics, Nektar Therapeutics, Allergy Hero and Allerayde UK, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Latex Allergy market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Latex Allergy.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Latex Allergy Market by Company
Sanofi
Johnson & Johnson
Novartis
Merck
GlaxoSmithKline
Rocky Mountain Diagnostics
Nektar Therapeutics
Allergy Hero
Allerayde UK
Alcon
3M
Latex Allergy Segment by Type
Skin Test
Allergy Test
Latex Allergy Segment by Application
Systemic Reaction
Allergic Contact Dermatitis
Others
Latex Allergy Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Latex Allergy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Latex Allergy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Latex Allergy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Latex Allergy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Skin Test
- Allergy Test
Applications
- Systemic Reaction
- Allergic Contact Dermatitis
- Others
Companies covered
- Sanofi
- Johnson & Johnson
- Novartis
- Merck
- GlaxoSmithKline
- Rocky Mountain Diagnostics
- Nektar Therapeutics
- Allergy Hero
- Allerayde UK
- Alcon
- 3M
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Latex Allergy by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Skin Test
- 2.2.3 Allergy Test
- 2.3 Latex Allergy by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Systemic Reaction
- 2.3.3 Allergic Contact Dermatitis
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Latex Allergy Breakdown Data by Type
- 3.1 Global Latex Allergy Historic Market Size by Type (2021-2026)
- 3.2 Global Latex Allergy Forecasted Market Size by Type (2027-2032)
4 Latex Allergy Breakdown Data by Application
- 4.1 Global Latex Allergy Historic Market Size by Application (2021-2026)
- 4.2 Global Latex Allergy Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Latex Allergy Market Perspective (2021-2032)
- 5.2 Global Latex Allergy Growth Trends by Region
- 5.2.1 Global Latex Allergy Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Latex Allergy Historic Market Size by Region (2021-2026)
- 5.2.3 Latex Allergy Forecasted Market Size by Region (2027-2032)
- 5.3 Latex Allergy Market Dynamics
- 5.3.1 Latex Allergy Industry Trends
- 5.3.2 Latex Allergy Market Drivers
- 5.3.3 Latex Allergy Market Challenges
- 5.3.4 Latex Allergy Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Latex Allergy Players by Revenue
- 6.1.1 Global Top Latex Allergy Players by Revenue (2021-2026)
- 6.1.2 Global Latex Allergy Revenue Market Share by Players (2021-2026)
- 6.2 Global Latex Allergy Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Latex Allergy Head Office and Area Served
- 6.4 Global Latex Allergy Players, Product Type & Application
- 6.5 Global Latex Allergy Manufacturers Established Date
- 6.6 Global Latex Allergy Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Latex Allergy Market Size (2021-2032)
- 7.2 North America Latex Allergy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Latex Allergy Market Size by Country (2021-2026)
- 7.4 North America Latex Allergy Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Latex Allergy Market Size (2021-2032)
- 8.2 Europe Latex Allergy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Latex Allergy Market Size by Country (2021-2026)
- 8.4 Europe Latex Allergy Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Latex Allergy Market Size (2021-2032)
- 9.2 Asia-Pacific Latex Allergy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Latex Allergy Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Latex Allergy Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Latex Allergy Market Size (2021-2032)
- 10.2 South America Latex Allergy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Latex Allergy Market Size by Country (2021-2026)
- 10.4 South America Latex Allergy Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Latex Allergy Market Size (2021-2032)
- 11.2 Middle East & Africa Latex Allergy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Latex Allergy Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Latex Allergy Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Sanofi
- 12.1.1 Sanofi Company Information
- 12.1.2 Sanofi Business Overview
- 12.1.3 Sanofi Revenue in Latex Allergy Business (2021-2026)
- 12.1.4 Sanofi Latex Allergy Product Portfolio
- 12.1.5 Sanofi Recent Developments
- 12.2 Johnson & Johnson
- 12.2.1 Johnson & Johnson Company Information
- 12.2.2 Johnson & Johnson Business Overview
- 12.2.3 Johnson & Johnson Revenue in Latex Allergy Business (2021-2026)
- 12.2.4 Johnson & Johnson Latex Allergy Product Portfolio
- 12.2.5 Johnson & Johnson Recent Developments
- 12.3 Novartis
- 12.3.1 Novartis Company Information
- 12.3.2 Novartis Business Overview
- 12.3.3 Novartis Revenue in Latex Allergy Business (2021-2026)
- 12.3.4 Novartis Latex Allergy Product Portfolio
- 12.3.5 Novartis Recent Developments
- 12.4 Merck
- 12.4.1 Merck Company Information
- 12.4.2 Merck Business Overview
- 12.4.3 Merck Revenue in Latex Allergy Business (2021-2026)
- 12.4.4 Merck Latex Allergy Product Portfolio
- 12.4.5 Merck Recent Developments
- 12.5 GlaxoSmithKline
- 12.5.1 GlaxoSmithKline Company Information
- 12.5.2 GlaxoSmithKline Business Overview
- 12.5.3 GlaxoSmithKline Revenue in Latex Allergy Business (2021-2026)
- 12.5.4 GlaxoSmithKline Latex Allergy Product Portfolio
- 12.5.5 GlaxoSmithKline Recent Developments
- 12.6 Rocky Mountain Diagnostics
- 12.6.1 Rocky Mountain Diagnostics Company Information
- 12.6.2 Rocky Mountain Diagnostics Business Overview
- 12.6.3 Rocky Mountain Diagnostics Revenue in Latex Allergy Business (2021-2026)
- 12.6.4 Rocky Mountain Diagnostics Latex Allergy Product Portfolio
- 12.6.5 Rocky Mountain Diagnostics Recent Developments
- 12.7 Nektar Therapeutics
- 12.7.1 Nektar Therapeutics Company Information
- 12.7.2 Nektar Therapeutics Business Overview
- 12.7.3 Nektar Therapeutics Revenue in Latex Allergy Business (2021-2026)
- 12.7.4 Nektar Therapeutics Latex Allergy Product Portfolio
- 12.7.5 Nektar Therapeutics Recent Developments
- 12.8 Allergy Hero
- 12.8.1 Allergy Hero Company Information
- 12.8.2 Allergy Hero Business Overview
- 12.8.3 Allergy Hero Revenue in Latex Allergy Business (2021-2026)
- 12.8.4 Allergy Hero Latex Allergy Product Portfolio
- 12.8.5 Allergy Hero Recent Developments
- 12.9 Allerayde UK
- 12.9.1 Allerayde UK Company Information
- 12.9.2 Allerayde UK Business Overview
- 12.9.3 Allerayde UK Revenue in Latex Allergy Business (2021-2026)
- 12.9.4 Allerayde UK Latex Allergy Product Portfolio
- 12.9.5 Allerayde UK Recent Developments
- 12.10 Alcon
- 12.10.1 Alcon Company Information
- 12.10.2 Alcon Business Overview
- 12.10.3 Alcon Revenue in Latex Allergy Business (2021-2026)
- 12.10.4 Alcon Latex Allergy Product Portfolio
- 12.10.5 Alcon Recent Developments
- 12.11 3M
- 12.11.1 3M Company Information
- 12.11.2 3M Business Overview
- 12.11.3 3M Revenue in Latex Allergy Business (2021-2026)
- 12.11.4 3M Latex Allergy Product Portfolio
- 12.11.5 3M Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst